View Older Stories View More Recent Stories
-
Hennessy Capital Investment Corp. V (HCIC) Prices 30M Unit IPO at $10/Unit
-
Village Farms International, Inc. (VFF) Announces US$135 Million Registered Direct Offering
-
Hennessy Capital Investment Corp. V Announces Pricing of Upsized $300,000,000 Initial Public Offering
-
Hennessy Capital Investment Corp. V Announces Pricing of Upsized $300,000,000 Initial Public Offering
-
Etsy (ETSY) Traffic Data Points to Another Strong Quarter - Roth Capital
-
Environmental Impact Acquisition Corp. (ENVI) Prices 18M Unit IPO at $10/Unit
-
Environmental Impact Acquisition Corp. Announces Pricing of Upsized $180 Million Initial Public Offering
-
Environmental Impact Acquisition Corp. Announces Pricing of Upsized $180 Million Initial Public Offering
-
Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Roth Canada Announces the Addition of Braden Fletcher as President
-
UPDATE: Roth Capital Downgrades GrowGeneration (GRWG) to Neutral (correction)
-
Veritone Named to Forbes’ 2021 List of Best Small-Cap Companies in America
-
UPDATE: Roth Capital Upgrades Ambarella (AMBA) to Buy
-
Roth Capital Raises the NV5 Holdings (NVEE) PT 66% to $136
-
Blink Charging Announces Closing of Public Offering of Common Stock for Total Gross Proceeds of $232.1 Million
-
Blink Charging Announces Closing of Public Offering of Common Stock for Total Gross Proceeds of $232.1 Million
-
Netlist (NLST) PT Raised to $1.50 at Roth Capital
-
Roth Capital Sees Tilly's (TLYS) Possibly Offering a Special Dividend, Preannounces Positive Results
-
Ideaya Biosciences (IDYA) Announces the IND Submission - Roth Capital
-
ReneSola Power Announces Closing of $40.0 Million Registered Direct Offering
-
Harpoon Therapeutics Announces Closing of Public Offering of Common Stock
-
Harpoon Therapeutics Announces Closing of Public Offering of Common Stock
-
Knowles Corp (KN) PT Raised to $23 at Roth Capital, Following Earnings
-
Remark Media (MARK) PT Raised to $5.25 at Roth Capital
-
Applied DNA Sciences (APDN) Prices 1.81M Share Registered Direct Offering at $8.30/Sh
-
Applied DNA Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Humanigen (HGEN) Announces Partnership to Commercialize Nasal Spray that Fights COVID Cytokine Storm, Expects EUA - Roth Capital
-
KemPharm (KMPH) Prices 7.69M Share Common and Warrant Offering at $6.50/Sh
-
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
-
Ideanomics CEO Alf Poor to Participate at the FORCE Family Office & Roth Capital Partners EV Symposium on January 8, 2021
-
Blink Charging (BLNK) Announces Pricing of Public Offering of Common Stock for Gross Proceeds of $221.4 million
-
Blink Charging Announces Pricing of its Public Offering of Common Stock for Gross Proceeds of $221.4 million
-
Blink Charging Announces Pricing of its Public Offering of Common Stock for Gross Proceeds of $221.4 million
-
Endeavour Silver Corp (EXK) PT Raised to $6 at Roth Capital After Production and Pricing Beat Expectations
-
McEwen Mining (MUX) PT Raised to $2 at Roth Capital After Update was Less Bad
-
InvestorNewsBreaks – Atara Biotherapeutics Inc. (NASDAQ: ATRA) Secures $175M in Underwritten Public Offering
-
InvestorNewsBreaks – Asure Software Inc. (NASDAQ: ASUR) Closes Public Offering of $18.9 Million
-
InvestorNewsBreaks – LivePerson Inc. (NASDAQ: LPSN) Closes $517.5M Convertible Senior Notes Offering
-
OptimizeRX (OPRX) PT Raised to Street High $70 at Roth Capital
-
INVO Bioscience Management Letter to Shareholders
-
Harpoon Therapeutics Inc. (HARP) Prices 5.88M Share Common Offering at $17/Sh
-
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
-
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
-
Harpoon Therapeutics Inc. (HARP) Announces Proposed Public Offering of Common Stock
-
Harpoon Therapeutics Announces Proposed Public Offering of Common Stock
-
Harpoon Therapeutics Announces Proposed Public Offering of Common Stock
-
InvestorNewsBreaks – Cellectar Biosciences Inc. (NASDAQ: CLRB) Secures $45M in Underwritten Public Offering and Concurrent Private Placement
-
XL Fleet to Participate in Upcoming Virtual Investor Conferences
-
UPDATE: Roth Capital Resumes Vista Outdoor (VSTO) at Buy
-
Clearside Biomedical (CLSD) Announces Pricing of $12 Million Registered Direct Offering

